Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.
Pallardy
Amandine
A
Nuclear Medicine Department, René Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France.
Bodet-Milin
Caroline
C
Oudoux
Aurore
A
Campion
Loïc
L
Bourbouloux
Emmanuelle
E
Sagan
Christine
C
Ansquer
Catherine
C
Testard
Aude
A
Resche
Isabelle
I
Bridji
Boumédiène
B
Kraeber-Bodéré
Françoise
F
Rousseau
Caroline
C
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging* / Q000628:therapy; D049268:Positron-Emission Tomography; D012189:Retrospective Studies; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed; D002583:Uterine Cervical Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy
D019788:Fluorodeoxyglucose F18